Navigation Links
Report recommends off-site disposal of secondary waste
Date:9/2/2007

hey are analyzed for contaminants, treated if necessary, and disposed of either on- or off-site. The committee found that disposal of these spent solutions does not present a significant challenge for the currently operating facilities, and so does not require any changes at this time.

In addition to secondary wastes, the report examines the regulatory requirements associated with trial burns at the incinerator facilities. Trial burns are used to ensure that 99.9999 percent of the toxic agents will be destroyed during regular operations. The time required to complete a trial burn, submit results, and obtain authorization for full operation can be very lengthy due to the time required to actually conduct the burn and the large amount of data that must be submitted and analyzed. However, under the Resource Conservation and Recovery Act (RCRA), which governs the disposal operations, these trials can potentially be avoided through the submission of data from a trial burn conducted in a sufficiently similar incinerator burning the same agent.

The committee found that because a trial burn has occurred for each type of incinerator with each agent, enough data exists to avoid further trial burns in many cases. The report recommends using this process of data submission in lieu of a trial burn to the fullest extent possible. The committee also recommends that the CMA should try to provide funding to state authorities for third-party analysis of trial burn data to shorten the time necessary for approval.


'/>"/>
Contact: Paul Jackson
news@nas.edu
202-334-2138
The National Academies
Source:Eurekalert

Page: 1 2 3 4

Related biology technology :

1. Assess the In Vivo Activation of Signal Transduction Pathways with PathDetect Reporting Systems
2. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
3. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
4. Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion Transactivators
5. Versatile Reporter Vectors for Monitoring Viral Transduction
6. In Vivo Signal Transduction Pathway Reporting Systems
7. Improved Vectors for PathDetect Trans-Reporting Systems
8. New Reporter Plasmids for Studying Interferon-Stimulated Signal Transduction Pathways
9. Cis-Reporting System Monitors Intracellular Calcium Mobilization
10. Cis-Reporting System Monitors Intracellular Calcium Mobilization
11. PatchMan - Test Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014  Decision Resources Group finds that the ... will grow moderately through 2023 as the aging population, ... of dental biomaterials all spur procedure volumes. Growth will ... China and India ... within reach for a larger proportion of the population. ...
(Date:12/17/2014)... The Activated Carbon Manufacturing ... why IBISWorld updated its original industry research report. ... an intensified focus on environmental policy. Over the five ... for power plants and a range of other industrial ... Analyst Sarah Kahn, “a range of downstream industrial sectors ...
(Date:12/17/2014)... 2014 Ipsen Biopharmaceuticals, Inc., an ... IPSEY), today announced that Somatuline® Depot® ... was approved by the U.S. Food and Drug ... tumors (GEP-NETs) in adult patients with unresectable, well ... to improve progression-free survival (PFS). , “The approval ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
Breaking Biology Technology:Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2
... 3 Trials on Track for Initiation Later This Year ... at 8:30 a.m. Eastern Time -, SAN DIEGO, ... announced today that an independent Echocardiographic,Data Safety Monitoring Board ... ongoing pivotal Phase 3 trial, BLOOM (Behavioral modification and,Lorcaserin ...
... 11 GeneGo, Inc. and the Cystic,Fibrosis Foundation ... for the integration and analysis of cystic fibrosis ... and,algorithms for understanding the complex interconnected pathways that ... this collaboration will better help us to understand ...
... in October At U.S. Psychiatric Congress, PARSIPPANY, ... that it has acquired the unique Bipolar Disorder,treatment, ... EQUETRO(R) is a treatment for the acute manic ... condition where patients experience,extended periods of exaggerated highs ...
Cached Biology Technology:Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review 2Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review 3Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review 4Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review 5Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review 6GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis 2GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis 3Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R) 2
(Date:12/17/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) ... Chemical Sensor Market 2015-2019" report to their ... One major trend upcoming in this ... in biomedical applications. Chemical sensors help in recording ... during surgical procedures. The Global Chemical Sensor market ...
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ...  report to their offering. One ... in technology. With continuous advances in technology, it ... latest standard that meets the needs and expectations ...
(Date:12/11/2014)... PAUL, Minn. , Dec. 10, 2014 /PRNewswire/ ... wireless physiologic monitoring, has released a new series ... needs of preclinical toxicology researchers. M series, part ... help toxicologists collect the best possible physiologic data ... Adding functional endpoints to toxicology studies ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
... Inc. and AmberGen, Inc. announced today that ... whereby AmberGen will provide its proprietary photocleavable ... SomaLogic,s SOMAscanTM technology platform. The ... high-throughput proteomic quantitation platform is achieving sufficient ...
... of rainbow trout -- one in Alaska, the other in ... implications for fisheries conservation and management, an eight-member research team ... of development that has allowed these different salmomid subspecies to ... researchers, in a paper put online ahead of publication in ...
... a plant pathologist. His most recent research project revolved ... analyzed a special class of genes that encode cell ... these enzymes when attacking a plant. But while investigating ... came in different sizes in different individuals. To ...
Cached Biology News:Genetic buzzer-beater genes may save fish 2Genetic buzzer-beater genes may save fish 3Shedding light on the 'dark matter' of the genome 2Shedding light on the 'dark matter' of the genome 3Shedding light on the 'dark matter' of the genome 4
Mouse polyclonal antibody to BTG2 - BTG family, member 2...
... to quantitate double-stranded DNA (dsDNA) in solution, even ... this kit, DNA is stained with Hoechst 33258 ... or other fluorometer. The kit quantitates dsDNA in ... 5 micrograms per ml and contains Hoechst 33258, ...
ImmunoPure Plus Immobilized Protein G, , , , Support: Cross-linked 6%, beaded agarose , Capacity: > 20 mg human IgG/ml of gel ...
... microplate readers combines reagent dispensing with fluorescence, ... easy-to-use platform for the complete range of ... and adaptability of the Infinite 200 series ... monochromator (M200) or filter (F200) system and ...
Biology Products: